Monthly Cost of Medicinal Cannabis Treatment Plummets 41% in 2 Years in Brazil
The research also highlights a 70% decrease in shipping costs, going from over R$ 400 to R$ 120, with the consolidation of the market in the country
Published on 01/12/2024
A study reveals that the average monthly cost of treatment with CBD, a key component of medicinal cannabis, in Brazil, has significantly decreased over the past two years. The survey, conducted by Cannect, shows an impressive 41% reduction, dropping from R$ 508.35 to around R$ 300. The decline is attributed to innovative strategies in the market, such as negotiations with partner brands and logistical integration, supported by an advanced technological platform.
Additionally, the research highlights a 70% decrease in shipping costs, going from over R$ 400 to R$ 120, thanks to the gradual consolidation of the medicinal cannabis market in the country. Medical and dental consultations related to treatment also saw a significant reduction of 42%, dropping from an average of R$ 300 to R$ 175.
Brazilian Medicinal Cannabis Congress
The primary scientific and professional congress in Latin America focused on bringing innovation and advancements related to the medicinal use of cannabis.
Allan Paiotti, CEO of Cannect, attributes the decrease in medical costs to the increasing acceptance and education of doctors about medicinal cannabis. The rise in scientific studies on its effectiveness in treating conditions such as epilepsy, anxiety, and chronic pain has broken taboos and expanded the number of professionals qualified to prescribe.
“For example, in 2015, when the first regulations on the subject were established in the country, few professionals had knowledge in prescribing, which limited the diversification of specialists and raised costs. With more prescribing doctors, patients benefit from access,” he explains.
However, a persistent challenge is the slow progress of legislative projects for the implementation of cannabis in the public health system. While treatment becomes more accessible to the population, bureaucratic delays negatively impact public funds, as seen in São Paulo, which faced record expenses in legal proceedings, reaching R$ 25.6 million.
